Skip to main content
. Author manuscript; available in PMC: 2022 Aug 19.
Published in final edited form as: CEUR Workshop Proc. 2020 Sep;2807:H.

Figure 4.

Figure 4.

Three clinical trials investigating Gleevec, imatinib mesylate, and imatinib for three different medical conditions. Boxes with blue lines are entities in PubChem scope. Boxes with black heavy lines are entities extracted from ClinicalTrials.gov. Light blue colored boxes denote ‘investigational molecular entity’ mentioned in the ClinicalTrials.gov.